Ditans: a new prospective for the therapy of migraine attack?
Giovanna ViticchiLorenzo FalsettiMauro SilvestriniMarco BartoliniPublished in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2022)
Lasmiditan could be a viable alternative to triptans, although further RCT studies and real-world evidence are needed to better understand its potential and possible adverse events in a larger population.
Keyphrases